A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial

Takayama, Shin, Namiki, Takao, Ito, Takashi, Arita, Ryutaro, Nakae, Hajime, Kobayashi, Seiichi, Yoshino, Tetsuhiro, Ishigami, Tomoaki, Tanaka, Koichiro, Mosaburo Kainuma, Nochioka, Kotaro, Takagi, Airi, Mimura, Masaru, Takuhiro Yamaguchi, Ishii, Tadashi

Open source

DOI: 10.6084/m9.figshare.c.5141417.v1
Published: 2020
Container: Not recorded
Publisher: figshare
Open access: yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.6084/m9.figshare.c.5141417.v1,
  title = {A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial},
  author = {Takayama, Shin and Namiki, Takao and Ito, Takashi and Arita, Ryutaro and Nakae, Hajime and Kobayashi, Seiichi and Yoshino, Tetsuhiro and Ishigami, Tomoaki and Tanaka, Koichiro and Mosaburo Kainuma and Nochioka, Kotaro and Takagi, Airi and Mimura, Masaru and Takuhiro Yamaguchi and Ishii, Tadashi},
  year = {2020},
  doi = {10.6084/m9.figshare.c.5141417.v1},
  url = {https://doi.org/10.6084/m9.figshare.c.5141417.v1}
}

RIS

TY  - JOUR
TI  - A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial
AU  - Takayama, Shin
AU  - Namiki, Takao
AU  - Ito, Takashi
AU  - Arita, Ryutaro
AU  - Nakae, Hajime
AU  - Kobayashi, Seiichi
AU  - Yoshino, Tetsuhiro
AU  - Ishigami, Tomoaki
AU  - Tanaka, Koichiro
AU  - Mosaburo Kainuma
AU  - Nochioka, Kotaro
AU  - Takagi, Airi
AU  - Mimura, Masaru
AU  - Takuhiro Yamaguchi
AU  - Ishii, Tadashi
PY  - 2020
DO  - 10.6084/m9.figshare.c.5141417.v1
UR  - https://doi.org/10.6084/m9.figshare.c.5141417.v1
ER  -

APA

Shin, T., Takao, N., Takashi, I., Ryutaro, A., Hajime, N., Seiichi, K., Tetsuhiro, Y., Tomoaki, I., Koichiro, T., Kainuma, M., Kotaro, N., Airi, T., Masaru, M., Yamaguchi, T., & Tadashi, I. (2020). A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial. https://doi.org/10.6084/m9.figshare.c.5141417.v1

Source records

datacite · retrieved 2026-09-26T04:19:48.886Z